A Tucson-based cancer drug company is looking to raise $29 million in an initial public offering of stock, and continues to raise private funding and form key partnerships.
Cancer Prevention Pharmaceuticals Inc. — whose leading drug candidate is based on technology developed partly at the University of Arizona — is waiting for the U.S. Securities and Exchange Commission to declare its stock registration statement effective, after which it will be priced and issued.
To submit your application for funding to Desert Angels in a way that will bring it to our immediate attention, please click here.
Joann MacMaster was elected to be the Chief Executive Officer of Desert Angels, Inc. in January 2020. Prior to taking on the CEO role with Desert Angels, MacMaster served as the Sr. Director of Venture Development for the University of Arizona’s TLA team, focused on the commercialization of university research through the development of startup companies. She has served as a startup founder, mentor, investor, and educator, and is a recipient of the Larry Hecker and Sherry Hoskinson Lasting Community Builder Award. She is an AUTM board member and UA Academic Leadership Institute Fellow and previously served as President of the Arizona Business Incubation Association. She returned home to Tucson in 2000 after living and working in Europe for over a decade and holds an MBA from Edinburgh University Scotland.
For reasons other than Applying to Desert Angels, if you would like to communicate with Joann for other reasons or receive an update on your funding request, you can email Joann by clicking Contact our CEO.
To submit your application for funding to Desert Angels in a way that will bring it to our immediate attention, please click here.
The Desert Angels Board of Directors elected Jeffrey Lang to serve as Chairman of the Board in January 2020. Prior to taking on this role, Jeffrey served on the Desert Angels Board. His career includes more than 30 years in roles including executive management experience as CEO, COO, CFO & CTO of companies from $10MM to $200MM turnover. For more than 10 years, Jeff has been actively involved in startup to mid-level angel and private equity investment, board level, and advisory efforts. As a member of Desert Angels, he has invested in more than 35 businesses involved with industries ranging across consumer products, medical instrumentation, software development, and healthcare research and product development.
For reasons other than Applying to Desert Angels, if you would like to communicate with Jeffrey for other reasons or receive an update on your funding request, you can email Jeffrey Lang, Board Chairman by clicking Contact our Chairman.